top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

9.655 +0.225 (+2.39%)

Streaming Delayed Price Updated: 12:38 PM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts

October 17, 2025

Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its...

Via MarketMinute

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors...

Via MarketMinute

Topics Fraud

Why Integra LifeSciences (IART) Shares Are Trading Lower Today

October 15, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell in the afternoon session after Truist kept a Hold rating on the shares. The analyst mentioned in a research note that they...

Via StockStory

Topics Artificial Intelligence Economy Government

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Integra LifeSciences (NASDAQ:IART) Misses Q3 Sales Expectations

October 30, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5.6% year on year to $402.1 million. Next quarter’s revenue guidance of...

Via StockStory

Integra LifeSciences (IART) Q3 Earnings Report Preview: What To Look For

October 28, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

2 Stocks Under $50 for Long-Term Investors and 1 We Question

October 21, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

3 Healthcare Stocks We Think Twice About

October 03, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Stocks

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

3 Reasons to Sell IART and 1 Stock to Buy Instead

September 30, 2025

Integra LifeSciences’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $13.34 per share. This might have investors contemplating their next move.

Via StockStory

Integra LifeSciences and LeMaitre Shares Are Falling, What You Need To Know

September 25, 2025

A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential...

Via StockStory

Topics World Trade

3 Cash-Burning Stocks We’re Skeptical Of

September 19, 2025

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

Why Integra LifeSciences (IART) Stock Is Down Today

September 08, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 3.6% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a warning letter regarding violations at...

Via StockStory

Topics Economy

September 02, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Spotting Winners: Integra LifeSciences (NASDAQ:IART) And Surgical Equipment & Consumables - Specialty Stocks In Q2

August 27, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

3 Russell 2000 Stocks We’re Skeptical Of

August 22, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Integra LifeSciences, IQVIA, Avantor, National Vision, and United Airlines Shares Plummet, What You Need To Know

August 21, 2025

A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell.

Via StockStory

Topics Economy Stocks

IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook

August 13, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $415.6 million. The company expects...

Via StockStory

Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Lawsuit

3 Value Stocks with Warning Signs

August 11, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

1 Volatile Stock to Target This Week and 2 We Avoid

August 07, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

3 Stocks Under $50 We Approach with Caution

August 05, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

Integra (IART) Q2 Revenue Beats by 5% ↗

July 31, 2025

Via The Motley Fool

Integra LifeSciences Holding (NASDAQ:IART) Reports Q2 2025 Earnings Beat Amid Mixed Market Reaction ↗

July 31, 2025

Integra LifeSciences (IART) Q2 2025 earnings beat revenue and EPS estimates, but shares dipped pre-market. Strong performance in neurosurgery and wound care segments drives growth.

Via Chartmill

Topics Earnings

Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets

July 31, 2025

Via StockStory

Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 29, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for.

Via StockStory

3 Profitable Stocks We Think Twice About

July 24, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page